Apex Labs Ltd. Revenue and Competitors
Estimated Revenue & Valuation
- Apex Labs Ltd.'s estimated annual revenue is currently $1.5M per year.
- Apex Labs Ltd.'s estimated revenue per employee is $100,500
Employee Data
- Apex Labs Ltd. has 15 Employees.
- Apex Labs Ltd. grew their employee count by 15% last year.
Apex Labs Ltd.'s People
Name | Title | Email/Phone |
---|---|---|
1 | CEO & Director | Reveal Email/Phone |
2 | Chief Science Officer & Director | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | Chief Cultivation Officer | Reveal Email/Phone |
5 | CSO & Director | Reveal Email/Phone |
Apex Labs Ltd. Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $33.4M | 166 | -10% | N/A | N/A |
#2 | $68.8M | 274 | 18% | $942.6M | N/A |
#3 | $23.5M | 117 | 0% | N/A | N/A |
#4 | $1.6M | 16 | 45% | $3.7M | N/A |
#5 | $0.7M | 7 | 0% | N/A | N/A |
#6 | $1.5M | 15 | 15% | N/A | N/A |
#7 | $1.4M | 14 | 17% | N/A | N/A |
#8 | $0.7M | 7 | -12% | N/A | N/A |
#9 | $17.7M | 88 | 24% | N/A | N/A |
#10 | $4.6M | 23 | -56% | N/A | N/A |
What Is Apex Labs Ltd.?
APEX Labs is a socially focused pharmaceutical company focused on psychedelic drug product to market for patients suffering from Post-Traumatic Disorder (PTSD), depression, addiction and other related mental health conditions. APEX’s Canadian clinical development program is focused on Veterans – groups that are most affected by these disorders. The Company’s lead clinical candidate is a low-dose synthetic psilocybin for the treatment of PTSD. To learn more please visit us at: www.apexlabs.com
keywords:N/AN/A
Total Funding
15
Number of Employees
$1.5M
Revenue (est)
15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.3M | 15 | N/A | N/A |
#2 | $2.5M | 15 | -25% | N/A |
#3 | $1.3M | 15 | N/A | N/A |
#4 | $2.9M | 15 | -12% | N/A |
#5 | $2.4M | 15 | 0% | N/A |